GL1X · GenesisL1 explorer

Research workbench

Rxra structure complexed with cu-6PMN and SRC1 peptide.

Analyse Rxra structure complexed with cu-6PMN and SRC1 peptide. in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6JNR
Type
protein
Length
448 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Retinoic acid receptor rxr-alpha; His-lys-ile-leu-his-arg-leu-leu-gln
UniProt
P19793
Ligands
WY5
Pockets
3 · best druggability 0.83

Structure

x-ray diffraction · 4 distinct chains · 70% helix, 3% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ARetinoic acid receptor rxr-alphaprotein21468% helix, 3% strandP19793
BRetinoic acid receptor rxr-alphaprotein21571% helix, 3% strandP19793
CHis-lys-ile-leu-his-arg-leu-leu-glnprotein978% helix, 0% strand—
DHis-lys-ile-leu-his-arg-leu-leu-glnprotein1070% helix, 0% strand—

Ligands and binding sites

  • WY5 · 7-oxidanyl-2-oxidanylidene-6-(3,5,5,8,8-pentamethyl-6, 7-dihydronaphthalen-2-yl)chromene-3-carboxylic acid · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13040.830.9341WY5
22840.830.9441WY5
38580.740.7863empty

Interfaces

3 interfaces between chains.

  • A–B · 1126 Ų buried · 11 hydrogen bonds · protein-protein
  • B–D · 590 Ų buried · 7 hydrogen bonds · protein-protein
  • A–C · 577 Ų buried · 6 hydrogen bonds · protein-protein

Compared structures

  • 6JNR · RXRa structure complexed with CU-6PMN and SRC1 peptide. · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.